Neurodegenerative disease profoundly affects structures and pathways responsible for memory, cognition, and higher-order ...
The approval of disease-modifying antiamyloid therapies has expanded the clinical role of amyloid PET beyond diagnostic confirmation to include baseline characterization and longitudinal monitoring of ...
Alzheimer disease (AD) is the most common cause of dementia and one of the leading causes of death in adults age 65 y or ...
We report the cases of 3 patients with biopsy-proven light-chain cardiac amyloidosis (AL-CA) presenting with varying clinical manifestations and abnormal findings on Tc-based bone-avid scintigraphy, ...
Amyloid PET has become a pivotal imaging biomarker for Alzheimer disease (AD), enabling in vivo detection and quantification of β-amyloid deposition. However, variability in quantitative measurements ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results